MX2020011004A - Sistema de microagujas para la aplicacion de interferon. - Google Patents

Sistema de microagujas para la aplicacion de interferon.

Info

Publication number
MX2020011004A
MX2020011004A MX2020011004A MX2020011004A MX2020011004A MX 2020011004 A MX2020011004 A MX 2020011004A MX 2020011004 A MX2020011004 A MX 2020011004A MX 2020011004 A MX2020011004 A MX 2020011004A MX 2020011004 A MX2020011004 A MX 2020011004A
Authority
MX
Mexico
Prior art keywords
microneedle system
interferon
applying interferon
applying
microneedle
Prior art date
Application number
MX2020011004A
Other languages
English (en)
Inventor
Stefan Henke
Andreas Henning
Rolf Pracht
Danny Brodkorb
Sebastian Scherr
Original Assignee
Lts Lohmann Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie Systeme Ag filed Critical Lts Lohmann Therapie Systeme Ag
Publication of MX2020011004A publication Critical patent/MX2020011004A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El invento que nos ocupa concierne a un sistema de microagujas (SMA) para la aplicación intradérmica de interferón, en el que la polivinilpirrolidona es el componente principal de una fórmula completamente soluble.
MX2020011004A 2018-04-19 2019-04-23 Sistema de microagujas para la aplicacion de interferon. MX2020011004A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102018109460 2018-04-19
DE102018114930 2018-06-21
PCT/EP2019/060396 WO2019202170A1 (de) 2018-04-19 2019-04-23 Mikronadelsystem zur applikation von interferon

Publications (1)

Publication Number Publication Date
MX2020011004A true MX2020011004A (es) 2020-11-09

Family

ID=66597522

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020011004A MX2020011004A (es) 2018-04-19 2019-04-23 Sistema de microagujas para la aplicacion de interferon.

Country Status (12)

Country Link
US (1) US20230330010A1 (es)
EP (1) EP3781127B1 (es)
JP (2) JP2021522171A (es)
KR (2) KR102658659B1 (es)
CN (1) CN112055582B (es)
AU (1) AU2019254726B2 (es)
BR (1) BR112020020159A2 (es)
CA (1) CA3097617C (es)
ES (1) ES2905483T3 (es)
MX (1) MX2020011004A (es)
PL (1) PL3781127T3 (es)
WO (1) WO2019202170A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102017112573A1 (de) * 2017-06-07 2018-12-13 Lts Lohmann Therapie-Systeme Ag Mikronadelsystem zur Applikation von Glukagon-ähnlichen-Peptid Analoga
DE102021118997A1 (de) 2021-07-22 2023-01-26 Lts Lohmann Therapie-Systeme Ag. Mikronadelarray mit Antiseptika
CN113599501B (zh) * 2021-08-25 2022-11-29 北京三元基因药业股份有限公司 一种稳定的干扰素微针制剂及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1294215C (en) * 1986-10-27 1992-01-14 Ze'ev Shaked Pharmaceutical compositions of recombinant beta-interferon and formulation processes
US6887462B2 (en) * 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
DE10353629A1 (de) 2003-11-17 2005-06-16 Lts Lohmann Therapie-Systeme Ag Vorrichtung zur transdermalen Verabreichung von Wirkstoffen
EP1940459B1 (en) 2005-09-06 2014-04-09 Theraject, Inc. Solid solution perforator containing drug particle and/or drug-adsorbed particles
PT2097068E (pt) * 2006-11-24 2013-10-23 Cadila Healthcare Ltd Formulações de conjugados de peg-interferão alfa
US20130041330A1 (en) * 2010-02-24 2013-02-14 Hisamitsu Pharmaceutical Co., Inc. Micro-needle device and preparation method
CN104069484A (zh) * 2014-03-28 2014-10-01 上海交通大学 干扰素微针及其制备方法和应用
KR101950693B1 (ko) * 2014-07-24 2019-02-21 주식회사 엘지생활건강 레티놀 또는 레티놀 유도체를 함유하는 마이크로니들
JP2018039761A (ja) * 2016-09-08 2018-03-15 コスメディ製薬株式会社 双針型マイクロニードル

Also Published As

Publication number Publication date
KR102658659B1 (ko) 2024-04-17
CA3097617C (en) 2023-01-24
EP3781127A1 (de) 2021-02-24
JP2023022124A (ja) 2023-02-14
KR20210003164A (ko) 2021-01-11
WO2019202170A1 (de) 2019-10-24
US20230330010A1 (en) 2023-10-19
EP3781127B1 (de) 2022-01-12
CN112055582B (zh) 2023-09-29
CA3097617A1 (en) 2019-10-24
BR112020020159A2 (pt) 2021-01-05
KR102555433B1 (ko) 2023-07-13
CN112055582A (zh) 2020-12-08
AU2019254726B2 (en) 2022-10-06
KR20230098709A (ko) 2023-07-04
AU2019254726A1 (en) 2020-11-12
JP2021522171A (ja) 2021-08-30
PL3781127T3 (pl) 2022-05-02
ES2905483T3 (es) 2022-04-08

Similar Documents

Publication Publication Date Title
MX2018014154A (es) Polinucleotidos moduladores.
MX2022009148A (es) Composiciones y metodos para el tratamiento de hemoglobinopatias.
MX2019003735A (es) Formulaciones diluibles de cannabinoides y procesos para su preparacion.
PT3577110T (pt) Compostos substituídos de 8-oxetan-3-il-3,8-diazabiciclo[3.2.1]octan-3-il como inibidores de vih
MX2023008686A (es) Polinucleotidos moduladores.
PH12019500494A1 (en) Formulations of (r)-2-amino-3-phenylpropyl carbamate
EP4282479A3 (en) Use of pridopidine to treat depression or anxiety
MX2020011004A (es) Sistema de microagujas para la aplicacion de interferon.
MX2020005641A (es) Recubrimiento anti-microbiano y metodo para formar el mismo.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
MY191539A (en) Streptococcal vaccine
MX2019013645A (es) Inhibidores de quinasa y usos de los mismos.
MX2021007245A (es) Microorganismos para la produccion de putrescina u ornitina y procedimiento para la produccion de putrescina u ornitina usando los mismos.
SG11201809434YA (en) Hair-growth agent
NZ732978A (en) Il-17a-binding polypeptides
MX2021000530A (es) Procedimiento de preparacion de (met)acrilatos acidos c-h.
MX2017010883A (es) Composicion para el tratamiento de la infertilidad.
MY165608A (en) Method for producing oxide catalyst, and method for producing unsaturated nitrile
BR112017004739A2 (pt) ligantes de hormônio folículo estimulante, complexo de ligante e gonadotrofina, uso de um ligante, e composição farmacêutica
PH12020550871A1 (en) Process for the preparation of opicapone and intermediates thereof
MX2021007914A (es) Composiciones curables que comprenden poliolefinas insaturadas.
MX2017015384A (es) Extension de horma de zapato.
NZ746356A (en) Lecithin-based spray adjuvant containing organosilicon wetting agents
MX2018004296A (es) Combinacion de un agonista selectivo de il-2rbeta y un agonista il-15 de accion prolongada.